Literature DB >> 29051175

Associations between residual depressive symptoms, cognition, and functioning in patients with euthymic bipolar disorder: results from the FACE-BD cohort.

Paul Roux1, Aurélie Raust2, Anne-Sophie Cannavo2, Valérie Aubin2, Bruno Aouizerate2, Jean-Michel Azorin2, Frank Bellivier2, Raoul Belzeaux2, Thierry Bougerol2, Iréna Cussac2, Philippe Courtet2, Bruno Etain2, Sébastien Gard2, Sophie Job2, Jean-Pierre Kahn2, Marion Leboyer2, Emilie Olié2, Chantal Henry2, Christine Passerieux2.   

Abstract

BackgroundThe relationship between residual depressive symptoms, cognition and functioning in patients with euthymic bipolar disorder is a subject of debate.AimsTo assess whether cognition mediates the association between residual depressive symptoms and functioning in patients with bipolar disorder who were euthymic.MethodWe included 241 adults with euthymic bipolar disorder in a multicentre cross-sectional study. We used a battery of tests to assess six cognition domains. A path analysis was then used to perform a mediation analysis of the relationship between residual depressive symptoms, cognitive components and functioning.ResultsOnly verbal and working memory were significantly associated with better functioning. Residual depressive symptoms were associated with poorer functioning. No significant relationship was found between residual depressive symptoms and any cognitive component.ConclusionsCognition and residual depressive symptoms appear to be two independent sources of variation in the functioning of people with euthymic bipolar disorder. © The Royal College of Psychiatrists 2017.

Entities:  

Mesh:

Year:  2017        PMID: 29051175     DOI: 10.1192/bjp.bp.117.201335

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN: 0007-1250            Impact factor:   9.319


  3 in total

Review 1.  Activation of SIRT-1 Signalling in the Prevention of Bipolar Disorder and Related Neurocomplications: Target Activators and Influences on Neurological Dysfunctions.

Authors:  Bidisha Rajkhowa; Sidharth Mehan; Pranshul Sethi; Aradhana Prajapati
Journal:  Neurotox Res       Date:  2022-02-14       Impact factor: 3.911

Review 2.  The Impact of Subsyndromal Bipolar Symptoms on Patient's Functionality and Quality of Life.

Authors:  Heinz Grunze; Christoph Born
Journal:  Front Psychiatry       Date:  2020-06-12       Impact factor: 4.157

3.  Neurocognitive effects of six ketamine infusions and the association with antidepressant effects in treatment-resistant bipolar depression: a preliminary study.

Authors:  Wei Zheng; Yan-Ling Zhou; Cheng-Yu Wang; Xiao-Feng Lan; Bin Zhang; Ming-Zhe Yang; Sha Nie; Yu-Ping Ning
Journal:  PeerJ       Date:  2020-11-03       Impact factor: 2.984

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.